Cash & equivalents decreased 61.4%
Cash & equivalents changed -61.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -61.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed -31.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed -27.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed -29.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +39.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Total assets changed -23.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed +39.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current liabilities changed -19.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -570 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed +27.4% from the comparable as-filed period.
Stock-based compensation changed -26.0% from the comparable as-filed period.
Shares outstanding changed +2.3% from the comparable as-filed period. The change ranks at the 43th percentile of 7 prior comparable changes.
Current ratio changed -10.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Research & development changed +7.7% from the comparable as-filed period.
Cost of revenue changed -10.6% from the comparable as-filed period.
Capital expenditure changed from 0 to 0 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Cash & equivalents changed -60.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -694 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed -31.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed -26.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed -22.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed -22.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -39.7% from the comparable as-filed period.
Free-cash-flow proxy changed -140.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash flow changed -140.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current liabilities changed -10.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed -18.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +29.2% from the comparable as-filed period.
Cost of revenue changed +53.4% from the comparable as-filed period.
Shares outstanding changed +2.3% from the comparable as-filed period. The change ranks at the 57th percentile of 7 prior comparable changes.
Stock-based compensation changed -15.7% from the comparable as-filed period.
Capital expenditure changed from 0 to 0 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.